Emergency Use Listing by WHO

Subject – Science and Tech

Context – Covaxin may get WHO approval soon

Concept –

The WHO EUL is a risk based procedure for assessing and listing unlicensed vaccines, therapeutics and in-vitro diagnostics with the ultimate aim of expediting the availability of these products to people affected by a public health emergency.
Emergency Use Listing (EUL) is the procedure to streamline the process by which new or unlicensed products can be used during public health emergencies.
The EUL replaces the Emergency Use Assessment and Listing (EUAL) procedure, which was used during the West Africa Ebola outbreak of 2014-2016.
The WHO established its emergency use listing (EUL) process to help poorer countries without their own regulatory resources quickly approve medicines new diseases like Covid-19, which otherwise could lead to delays.
The EUL is not intended to interfere with ongoing clinical trials.
The process may include on-site inspections of the company’s facilities.